Bone: Reference bone turnover markers-just a fairy tale?

Nature Reviews Endocrinology

Volumn 7, Issue 9, 2011, Pages 502-504

  Seibel, Markus J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; COLLAGEN TYPE 1;

BIOASSAY; BODY MASS; BONE DENSITY; BONE TURNOVER; CLINICAL ASSESSMENT; CROSS LINKING; FRACTURE; OSTEOPOROSIS; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; STANDARDIZATION;

BONE AND BONES; BONE DENSITY; HUMANS; OSTEOPOROSIS;

EID: 80052059972     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2011.121     Document Type: Review

References (10)

1. Vasikaran, S. et al. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis. Clin. Chem. Lab. Med. doi:10.1515/CCLM.2011.602.
2. van Daele, P. L. et al. Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. BMJ 312, 482-483 (1996). (Pubitemid 26061239)
3. Ivaska, K. K., Gerdhem, P., Väänänen, H. K., Akesson, K. & Obrant, K. J. Bone turnover markers and prediction of fracture: a prospective follow-up study of elderly women for a mean of 9 years. J. Bone Miner. Res. 25, 393-403 (2010).
4. Bauer, D. C. et al. Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial. J. Bone Miner. Res. 19, 1250-1258 (2004). (Pubitemid 41094365)
5. Sarkar, S. et al. Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk. J. Bone Miner. Res. 19, 394-401 (2004). (Pubitemid 38787394)
6. Seibel, M. J., Lang, M. & Geilenkeuser, W. J. Interlaboratory variation of biochemical markers of bone turnover. Clin. Chem. 47, 1443-1450 (2001). (Pubitemid 32678824)
7. Overgaard, K., Alexandersen, P., Riis, B. J. & Christiansen, C. Evaluation of a new commercial IRMA for bone-specific alkaline phosphatase during treatment with hormone replacement therapy and calcitonin. Clin. Chem. 42, 973-974 (1996).
8. Meier, C., Nguyen, T. V., Center, J. R., Seibel, M. J. & Eisman, J. A. Bone resorption and osteoporotic fractures in elderly men: the Dubbo osteoporosis epidemiology study. J. Bone Miner. Res. 20, 579-587 (2005). (Pubitemid 40393065)
9. Hannon, R. A. et al. Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption. Bone 34, 187-194 (2004). (Pubitemid 38142448)
10. Meunier, P. J. et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N. Engl. J. Med. 350, 459-468 (2004). (Pubitemid 38133766)